In the proposed project the investigators want to assess whether the approach of the
post-conditioning by Levosimendan in patients with acute STEMI is safe and reproducible, can
be used with a positive influence on the outcomes with respect to myocardial damage, cardiac
left ventricular remodeling, myocardial function, the occurrence of cardiac events and
quality of life.